TLRY
Tilray Brands, Inc.
Key Financials
Revenue
$821.3M
↑ 4.1%
Gross Profit
$240.6M
↑ 7.7%
Net Income
$-2186738000
↓ 792.6%
Total Assets
$2.1B
↓ 50.9%
EPS (Diluted)
$-2.46
↓ 645.5%
Operating Income
$-2282705000
↓ 1206.3%
Shareholders' Equity
$1.5B
↓ 56.1%
Total Liabilities
$584.8M
↓ 24.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 424B5 | 4/15/2026 | View on SEC |
| 8-K | 4/15/2026 | View on SEC |
| 8-K | 4/15/2026 | View on SEC |
| 10-Q | 4/1/2026 | View on SEC |
| 8-K | 4/1/2026 | View on SEC |
| 8-K | 3/2/2026 | View on SEC |
| 10-Q | 1/8/2026 | View on SEC |
| 4 | 1/8/2026 | View on SEC |
| 8-K | 1/8/2026 | View on SEC |
| 8-K | 11/26/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TLRY |
| Company Name | Tilray Brands, Inc. |
| CIK | 1731348 |
| Sector | Medicinal Chemicals & Botanical Products |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2833 |
| SIC Description | Medicinal Chemicals & Botanical Products |
| Entity Type | operating |
| Fiscal Year End | 0531 |
| Phone | 519.322.8800 |